Introduction to Drug Safety and Pharmacovigilance
The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Collectively, these developments have not overturned the favorable benefit-risk profile of paracetamol in appropriate clinical settings. Rather, they have transformed its safety narrative from one of presumed harmlessness to one requiring the same critical pharmacovigilance applied to other used analgesics [ 43 ].”
From Paracetamol: A History of Assumptions, Errors, and Evidence Reversals in Pain Management (2026) · cites this paper as [43]
Citations
Cites
Revolutionizing healthcare: the role of artificial intelligence in clinical practice
Alowais, S. A., Alghamdi, S. S., Alsuhebany, N., Alqahtani, T., Alshaya, A. I., Almohareb, S. N., Aldairem, A., Alrashed, M., Bin Saleh, K., Badreldin, H. A., et al. (2023) · BMC Medical Education · doi:10.1186/s12909-023-04698-z · Cited by 3,146
Adverse drug reactions: definitions, diagnosis, and management
Edwards, I. R., & Aronson, J. K. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02799-9 · Cited by 2,979
Panagioti, M., Khan, K., Keers, R. N., Abuzour, A., Phipps, D., Kontopantelis, E., Bower, P., Campbell, S., Haneef, R., Avery, A. J., et al. (2019) · BMJ · doi:10.1136/bmj.l4185 · Cited by 874
Reeve, E., Gnjidic, D., Long, J., & Hilmer, S. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12732 · Cited by 855
Onakpoya, I. J., Heneghan, C. J., & Aronson, J. K. (2016) · BMC Medicine · doi:10.1186/s12916-016-0553-2 · Cited by 616
Swen, J. J., van der Wouden, C. H., Manson, L. E., Abdullah-Koolmees, H., Blagec, K., Blagus, T., Böhringer, S., Cambon-Thomsen, A., Cecchin, E., Cheung, K.-C., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(22)01841-4 · Cited by 556
Council for International Organizations of Medical Sciences (CIOMS)
(2025) · Cobert's Manual of Drug Safety and Pharmacovigilance · doi:10.1142/9789811297724_0006 · Cited by 543
Pirmohamed, M., Breckenridge, A. M., Kitteringham, N. R., & Park, B. K. (1998) · BMJ · doi:10.1136/bmj.316.7140.1295 · Cited by 454
Nuckols, T. K., Smith-Spangler, C., Morton, S. C., Asch, S. M., Patel, V. M., Anderson, L. J., Deichsel, E. L., & Shekelle, P. G. (2014) · Systematic Reviews · doi:10.1186/2046-4053-3-56 · Cited by 340
Clarification of Terminology in Drug Safety
Aronson, J. K., & Ferner, R. E. (2005) · Drug Safety · doi:10.2165/00002018-200528100-00003 · Cited by 328
Research works printed but not linked: 16
- Rawlins MD. Pharmacovigilance: paradise lost, regained or postponed? The William Withering Lecture 1994. J R Coll Physicians Lond. 1995;29(1):41–9.
- Mann R, Andrew E. The Basis of pharmacovigilance: introduction. In: Mann R, Andrews E, editors. Pharmacovigilance. 2nd ed. Chichester: John Wiley and Sons Ltd; 2007. p. 3–11.
- Routledge P. 150 years of pharmacovigilance. Lancet (London, England). 1998;351(9110):1200–1. https://doi.org/10.1016/S0140-6736(98)03148. · doi:10.1016/s0140-6736(98)03148
- Stephens MD. The dawn of drug safety. Hampshire: George Mann; 2010.
- Shafique S. Thalidomide—an overview and the species-specific teratogenicity. Res J Congenit Dis. 2019;2:1.
- McBride WG. Thalidomide and congenital abnormalities. Lancet. 1961;2(1358):90927–8.
- Mohamed IN. Pharmacovigilance and reporting adverse drug reactions. Med Health. 2014;9(2):92–102.
- World Health Organization. International drug monitoring: the role of national centres. Technical report series no. 498. Geneva: WHO; 1972.
- International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. ICH Topic E 2 A clinical safety data management: definitions and standards for expedited reporting. 1995. Available at: https://www.ema.europa.eu/en/documents/scientific-guideline/international-conference-harmonisation-technical-requirements-registration-pharmaceuticals-human-use_en-15.pdf. Accessed 3 Aug 2022.
- Krska K, Cox AR. Adverse drug reactions. In: Whittlesea K, Hodson K, editors. Clinical pharmacy and therapeutics. 6th ed. Oxford: Elsevier; 2019.
- European Medicine Agency. Clinical safety data management: definitions and standards for expedited reporting. 1995. https://www.ema.europa.eu/en/documents/scientific-guideline/international-conference-harmonisation-technical-requirements-registration-pharmaceuticals-human-use_en-15.pdf.
- Dipiro CV. Obesity. In: Schwinghammer TL, Dipiro JT, Ellingrod VL, Dipiro CV, editors. Dipiro’s pharmacotherapy handbook. 12th ed. McGraw Hill; 2023. p. 657–6.
- Pichler WJ. Adverse side-effects to biological agents. Allergy. 2006;61(8):912–20. https://doi.org/10.1111/j.1398-9995.2006.01058. · doi:10.1111/j.1398-9995.2006.01058
- Ventola CL. Big data and pharmacovigilance: data mining for adverse drug events and interactions. P T. 2018;43(6):340–51.
- Dimbil M, Kyle R, Brown JS, Aldairy W. Using real-world data for rapid safety investigations: value of near-real-time clinical data querying. Drug Saf. 2022;45(10):1251–2.
- Frontiers in Pharmacology. Pharmacoinformatics: new developments and challenges in drug design. Available at: https://www.frontiersin.org/research-topics/50433/pharmacoinformatics-new-developments-and-challenges-in-drug-design. Accessed 23 Sept 2023.
Cited by
Mantia, G. L., Marcon, G., Coppini, M., Buttacavoli, F., Panzarella, V., Colella, G., Capuano, A., Sportiello, L., Parrinello, G., Morreale, I., et al. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1572611 · Cited by 4
Paracetamol: A History of Assumptions, Errors, and Evidence Reversals in Pain Management
Nicolas, J., Leoni, M. L. G., Van Tran, Y., Van Phong, P., Farì, G., Puttini, P. S., Kaye, A. D., & Varrassi, G. (2026) · Current Pain and Headache Reports · doi:10.1007/s11916-026-01553-w
Tools and Resources for Managing Drug Interactions
Nagu, P., Thakur, A., Singh, R., & Mehta, V. (2026) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898814328126010012
Metadata
- Authors
- Jose, J., Cox, A. R., & Bate, A.
- Affiliations
- GlaxoSmithKline (United Kingdom) (GB)
- Venue
- Principles and Practice of Pharmacovigilance and Drug Safety
- Publisher
- Springer International Publishing
- Published
- 2024
- Pages
- 3-30
- OpenAlex
- W4401337825
- Cited by
- 3
- References
- 79
- Citations by year
- 2026: 2 · 2025: 1
- FWCI
- 6.02
- Type
- book chapter
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Springer eBooks (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Patient Safety and Medication Errors
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Keywords
- drug safety, pharmacovigilance, adverse drug reactions, spontaneous reporting, post-marketing surveillance, real-world data, clinical trial limitations, medication errors, polypharmacy, pharmacoinformatics, artificial intelligence, pharmacogenomics, drug safety regulation, history of pharmacovigilance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Introduction to Drug Safety and Pharmacovigilance. https://app.cochat.ai/papers/10.1007/978-3-031-51089-2_1
- The paper
- Jose, J., Cox, A. R., & Bate, A. (2024). Introduction to Drug Safety and Pharmacovigilance. Principles and Practice of Pharmacovigilance and Drug Safety. https://doi.org/10.1007/978-3-031-51089-2_1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.